Understanding the stereochemistry of a chiral pharmaceutical drug allows medicinal chemists to synthesize and prepare the drug either in an enatiomerically ( or diastereomerically) enriched form, or as a racemic mixture of the various stereoisomers. What are the economics of manufacturing a drug either as a racemic mixture or in its biologically active form?
The high cost of drugs has forced some people to take drastic action such as leaving the US to buy drugs in other countries. Suggest alternative approaches to solving this problem.